FDA Adverse Event Injury Summary report: N

PRECISION SPECTRA®

MDR report key: 4123995 · Received September 27, 2014

Report

Report Number
3006630150-2014-02212
Event Type
Injury
Date Received
September 27, 2014
Date of Event
July 28, 2014
Report Date
September 5, 2014
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
PMA / PMN Number
030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT THE IPG HAD MIGRATED AND WAS NOT IN A FLAT POSITION WHICH WAS CAUSING THE DISCOMFORT AND DIFFICULTY CHARGING. THE IPG WAS REPOSITIONED DEEPER INTO THE BUTTOCKS.

Additional Manufacturer Narrative · 1

.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT HAD DIFFICULTY CHARGING THE IPG AND HAD POCKET SITE DISCOMFORT. IT WAS ALSO REPORTED THAT THE IPG HAD APPARENTLY SETTLED HORIZONTALLY UNDER THE SKIN. THE PATIENT UNDERWENT AN IPG REVISION. THE PATIENT WAS REPORTEDLY DOING WELL POSTOPERATIVELY.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT HAD DIFFICULTY CHARGING THE IPG AND HAD POCKET SITE DISCOMFORT. IT WAS ALSO REPORTED THAT THE IPG HAD APPARENTLY SETTLED HORIZONTALLY UNDER THE SKIN. THE PATIENT UNDERWENT AN IPG REVISION. THE PATIENT WAS REPORTEDLY DOING WELL POSTOPERATIVELY.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT HAD DIFFICULTY CHARGING THE IPG AND HAD POCKET SITE DISCOMFORT. IT WAS ALSO REPORTED THAT THE IPG HAD APPARENTLY SETTLED HORIZONTALLY UNDER THE SKIN. THE PATIENT UNDERWENT AN IPG REVISION. THE PATIENT WAS REPORTEDLY DOING WELL POSTOPERATIVELY. MONOPOLAR ELECTROCAUTERY IS A KNOWN SOURCE OF HIGH VOLTAGE TRANSIENT SIGNAL AND CURRENT COMPANY LABELING WARNS AGAINST THE USE OF MONOPOLAR ELECTROCAUTERY. (PHYSICIAN¿S IMPLANT MANUAL).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
603762 PRECISION SPECTRA® SPINAL CORD STIMULATOR LGW BOSTON SCIENTIFIC NEUROMODULATION SC-1132 NA

Patients

Seq Age Sex Outcome Treatment
1 57 YR Required Intervention